News & Updates

Add-on pembrolizumab–tocilizumab combo reduces hospitalization period in severe COVID-19
Add-on pembrolizumab–tocilizumab combo reduces hospitalization period in severe COVID-19
29 Aug 2022

In the treatment of patients with severe COVID-19, adding the combination of pembrolizumab plus tocilizumab to standard of care (SOC) appears to result in higher and faster discharge from the hospital without sequelae, as shown in the proof-of-concept phase II COPERNICO trial.

Add-on pembrolizumab–tocilizumab combo reduces hospitalization period in severe COVID-19
29 Aug 2022
Early transition to oral antimicrobials prevents treatment failure in children with SAB, AHO
Early transition to oral antimicrobials prevents treatment failure in children with SAB, AHO
27 Aug 2022
COVID-19 lockdowns reduce exercise in CIED patients
COVID-19 lockdowns reduce exercise in CIED patients
23 Aug 2022 byTristan Manalac

Patients with cardiac implantable electronic devices (CIED) see lower levels of physical activity during the COVID-19 pandemic, especially during a period of lockdown, according to a recent Germany study. While younger patients resume exercise with the easing of restrictions, older patients tend to remain inactive.

COVID-19 lockdowns reduce exercise in CIED patients
23 Aug 2022
Which factors predict relapse after antiviral therapy cessation in paediatric CHB?
Which factors predict relapse after antiviral therapy cessation in paediatric CHB?
19 Aug 2022